Oct. 04, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Integrated Cannabis”) is pleased to announce the successful completion and positive results of a controlled trial of its proprietary Sleep product.
Read more
Integrated Cannabis Company, Inc. Announces Positive Results from Clinical Study of X-SPRAYS Sleep Product
